Sarah Rickwood | pharmaphorum

Sarah Rickwood

Market Access

prescription medicine

Pharma’s post-pandemic launch performance problem: what’s th...

The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth.

Views & Analysis

Pandemic commercial models and launch

Nine for 2021: The COVID-19 legacy

In the first of a two part series, IQVIA's Sarah Rickwood covers nine key trends and events that will affect the global healthcare and pharmaceutical industries in 2021.

Sales & Marketing

Time to change the channel? The future for customer engagement models

Time to change the channel? The future for customer engageme...

Sarah Rickwood delves into IQVIA data to find out exactly how pharma's HCP engagement has changed over COVID-19, and what the channel mix might look like after the pandemic.

Views & Analysis

Pandemic commercial models and launch

A sea-change for pharma? Pandemic commercial models and laun...

Sarah Rickwood looks at how COVID-19 is changing pharma’s commercial models and launch strategies.

Views & Analysis

The concept of a new year with new ideas. Hand showing light bulb with luminous numbers 2020.

Nine for 2019: how did we do on our predictions, and what do...

Year-ends prompt reflection, both on what’s happened in the last 12 months and on the year ahead.

Views & Analysis

How-new-technologies-are-creating-new-markets-1200x675-Feature

How new technologies are creating new markets

Sarah Rickwood looks at why the next frontier for pharmaceutical innovation may not be a pharmaceutical at all, and how this will affect launch